• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Trending

Reverse Stock Split

Ex Date: 2025.12.24 (EST), 1-for-4 Reverse Stock Split

Event Tracking

May1
XTL BioPharma released FY2024 Q4 earnings on April 30 (EST), actual revenue USD 405 K, actual EPS USD -0.0909
03:00
XTL BioPharma released FY2024 annual earnings on April 30 (EST), actual revenue USD 451 K, actual EPS USD -0.2999
03:00
Apr30
XTL Biopharma Reports $1.03M Net Loss in Fiscal Year 2024
20:02
Dec31
XTL BioPharma released FY2024 Q3 earnings on December 30 (EST) with actual revenue of 46 K USD and EPS of -0.1333 USD
04:00
XTL BioPharma released FY2024 Semi-Annual Earnings on December 30 (EST) with actual revenue of 0 USD and EPS of -0.0401 USD
04:00
XTL BioPharma released FY2024 9 Months Earnings on December 30 (EST), with actual revenue of 46K USD and EPS of -0.1844 USD
04:00

Schedules & Filings

Schedules
Filings
Dec24
Reverse Stock Split(EST)

1-for-4 Reverse Stock Split

Apr30
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 405 K, Net Income -255 K, EPS -0.0909

Dec30
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 46 K, Net Income -553 K, EPS -0.1333

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More